Insmed Incorporated
INSM
$189.70
$4.022.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 447.02M | 398.11M | 381.03M | 363.71M | 342.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 447.02M | 398.11M | 381.03M | 363.71M | 342.96M |
| Cost of Revenue | 104.87M | 96.67M | 89.56M | 85.74M | 78.03M |
| Gross Profit | 342.15M | 301.43M | 291.47M | 277.97M | 264.92M |
| SG&A Expenses | 631.20M | 563.75M | 515.56M | 461.12M | 408.13M |
| Depreciation & Amortization | 5.33M | 5.05M | 5.05M | 5.05M | 5.05M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.44B | 1.33B | 1.24B | 1.15B | 1.05B |
| Operating Income | -990.28M | -927.68M | -859.01M | -786.57M | -703.93M |
| Income Before Tax | -1.18B | -1.03B | -1.01B | -910.07M | -860.85M |
| Income Tax Expenses | 4.74M | 4.44M | 4.03M | 3.71M | 3.44M |
| Earnings from Continuing Operations | -1.18K | -1.03K | -1.01K | -913.77 | -864.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.18B | -1.03B | -1.01B | -913.77M | -864.29M |
| EBIT | -990.28M | -927.68M | -859.01M | -786.57M | -703.93M |
| EBITDA | -978.79M | -917.46M | -849.84M | -777.70M | -695.06M |
| EPS Basic | -6.18 | -5.70 | -5.95 | -5.59 | -5.56 |
| Normalized Basic EPS | -3.33 | -3.29 | -3.22 | -3.11 | -2.97 |
| EPS Diluted | -6.19 | -5.71 | -5.95 | -5.59 | -5.56 |
| Normalized Diluted EPS | -3.33 | -3.29 | -3.22 | -3.11 | -2.97 |
| Average Basic Shares Outstanding | 760.94M | 722.90M | 688.30M | 655.90M | 621.69M |
| Average Diluted Shares Outstanding | 760.94M | 722.90M | 688.30M | 655.90M | 621.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |